LASILIX Side Effects

6642714-9 | Fall, Renal Failure Acute, Rhabdomyolysis
on Mar 09, 2010 Male patient from FRANCE , 83 years of age, was treated with Lasilix (View Usage). Patient experienced the following unwanted or unexpected effects: fall (What is fall?), renal failure acute, rhabdomyolysis. Lasilix dosage: . During the same period patient was treated with MICARDIS (View Micardis Review and Micardis Label ), CARDENSIEL (View Cardensiel Review and Cardensiel Label ), PREVISCAN (View Previscan Review and Previscan Label ), EUPRESSYL (View Eupressyl Review and Eupressyl Label ). Patient was hospitalized.

6640064-8 | Hypokalaemia, Hyponatraemia
Patient was taking Lasilix (View Usage). Patient had the following side effects: hypokalaemia, hyponatraemia on Mar 15, 2010 from FRANCE Additional patient health information: Female patient , 88 years of age, . Lasilix dosage: . During the same period patient was treated with COVERSYL /FRA/ (View Coversyl /fra/ Review and Coversyl /fra/ Label ), TAHOR (View Tahor Review and Tahor Label ), CARDENSIEL (View Cardensiel Review and Cardensiel Label ), CORDARONE (View Cordarone Review and Cordarone Label ), ESOMEPRAZOLE (View Esomeprazole Review and Esomeprazole Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), PLAVIX (View Plavix Review and Plavix Label ), TRANXENE (View Tranxene Review and Tranxene Label ). Patient was hospitalized.

6640061-2 | Toxic Epidermal Necrolysis
Adverse event was reported on Mar 12, 2010 by a Female patient taking Lasilix (View Usage) (Dosage: ) . Location: FRANCE , 87 years of age, After Lasilix was administered, patient had the following side effects: toxic epidermal necrolysis. During the same period patient was treated with ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), DIAMICRON (View Diamicron Review and Diamicron Label ), FENOFIBRATE (View Fenofibrate Review and Fenofibrate Label ), COTRIATEC, COMPRIME (View Cotriatec, Comprime Review and Cotriatec, Comprime Label ), ASPEGIC 1000 (View Aspegic 1000 Review and Aspegic 1000 Label ), TAHOR (View Tahor Review and Tahor Label ), VASTAREL ^SERVIER^ (View Vastarel ^servier^ Review and Vastarel ^servier^ Label ), NOVONORM (View Novonorm Review and Novonorm Label ). Patient was hospitalized.

6634969-1 | Axonal Neuropathy, Blood Creatine Phosphokinase Increased, Myalgia, Osteoporosis, Renal Failure Chronic
on Mar 03, 2010 Female patient from FRANCE , 69 years of age, weighting 130.1 lb, was diagnosed with osteoporosis (What is osteoporosis?), gastroduodenal ulcer and was treated with Lasilix (View Usage). Patient experienced the following unwanted or unexpected effects: axonal neuropathy, blood creatine phosphokinase increased, myalgia, osteoporosis (What is osteoporosis?), renal failure chronic. Lasilix dosage: . During the same period patient was treated with ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), ROSUVASTATIN (View Rosuvastatin Review and Rosuvastatin Label ), STRONTIUM RANELATE (View Strontium Ranelate Review and Strontium Ranelate Label ), INIPOMP (View Inipomp Review and Inipomp Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ), DIFFU K (View Diffu K Review and Diffu K Label ), VERAPAMIL (View Verapamil Review and Verapamil Label ). Patient was hospitalized.


6610019-8 | Areflexia, Hypokinesia, Muscular Weakness, Myopathy
on Feb 18, 2010 Female patient from FRANCE , 59 years of age, was treated with Lasilix (View Usage). Patient had the following side effects: areflexia, hypokinesia, muscular weakness, myopathy. Lasilix dosage: . During the same period patient was treated with CORDARONE (View Cordarone Review and Cordarone Label ), NAVELBINE (View Navelbine Review and Navelbine Label ), TAHOR (View Tahor Review and Tahor Label ), FLECAINIDE ACETATE (View Flecainide Acetate Review and Flecainide Acetate Label ), LEVOTHYROX (View Levothyrox Review and Levothyrox Label ). Patient was hospitalized.

6608171-3 | Fall, Hypoglycaemia, Injury, Loss Of Consciousness, Malaise
Patient was taking Lasilix (View Usage). After Lasilix was administered, patient had the following side effects: fall (What is fall?), hypoglycaemia, injury, loss of consciousness, malaise on Feb 16, 2010 from FRANCE Additional patient health information: Female patient , 80 years of age, . Lasilix dosage: . During the same period patient was treated with AMAREL (View Amarel Review and Amarel Label ), PROPOFAN (View Propofan Review and Propofan Label ), TEMESTA (View Temesta Review and Temesta Label ), LEXOMIL (View Lexomil Review and Lexomil Label ), ESOMEPRAZOLE (View Esomeprazole Review and Esomeprazole Label ), LEVOTHYROX (View Levothyrox Review and Levothyrox Label ), TAREG (View Tareg Review and Tareg Label ), PREVISCAN (View Previscan Review and Previscan Label ). Patient was hospitalized.

6585136-1 | Hyperkalaemia, Renal Failure Acute
Adverse event was reported on Feb 16, 2010 by a Female patient taking Lasilix (View Usage) (Dosage: ) . Location: FRANCE , 83 years of age, Patient experienced the following unwanted or unexpected effects: hyperkalaemia, renal failure acute. During the same period patient was treated with TRIATEC (View Triatec Review and Triatec Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), PREVISCAN (View Previscan Review and Previscan Label ), CARDENSIEL (View Cardensiel Review and Cardensiel Label ). Patient was hospitalized.

6582376-2 | Eosinophil Count Increased, Lymphadenopathy, Pyrexia, Rash Papular, Renal Failure
on Feb 10, 2010 Male patient from FRANCE , 80 years of age, was treated with Lasilix (View Usage). Patient had the following side effects: eosinophil count increased, lymphadenopathy, pyrexia, rash papular, renal failure. Lasilix dosage: . During the same period patient was treated with LASILIX FAIBLE (View Lasilix Faible Review and Lasilix Faible Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), SEROPLEX (View Seroplex Review and Seroplex Label ), FORLAX (View Forlax Review and Forlax Label ), EQUANIL (View Equanil Review and Equanil Label ), CACIT D3 (View Cacit D3 Review and Cacit D3 Label ), CASODEX (View Casodex Review and Casodex Label ), COUMADIN (View Coumadin Review and Coumadin Label ). Patient was hospitalized.

6582375-0 | Eosinophil Count Increased, Lymphadenopathy, Pyrexia, Rash Papular, Renal Failure
on Feb 10, 2010 Male patient from FRANCE , 80 years of age, was treated with Lasilix (View Usage). After Lasilix was administered, patient had the following side effects: eosinophil count increased, lymphadenopathy, pyrexia, rash papular, renal failure. Lasilix dosage: . During the same period patient was treated with LASILIX FAIBLE (View Lasilix Faible Review and Lasilix Faible Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), SEROPLEX (View Seroplex Review and Seroplex Label ), FORLAX (View Forlax Review and Forlax Label ), EQUANIL (View Equanil Review and Equanil Label ), CACIT D3 (View Cacit D3 Review and Cacit D3 Label ), CASODEX (View Casodex Review and Casodex Label ), COUMADIN (View Coumadin Review and Coumadin Label ). Patient was hospitalized.

6573664-4 | Aggression, Confusional State, Hallucination, Persecutory Delusion
Patient was taking Lasilix (View Usage). Patient experienced the following unwanted or unexpected effects: aggression, confusional state, hallucination, persecutory delusion on Feb 01, 2010 from FRANCE Additional patient health information: Female patient , 88 years of age, was diagnosed with insomnia, hyperuricaemia and. Lasilix dosage: . During the same period patient was treated with STILNOX (View Stilnox Review and Stilnox Label ), CARDENSIEL (View Cardensiel Review and Cardensiel Label ), HEMIGOXINE NATIVELLE (View Hemigoxine Nativelle Review and Hemigoxine Nativelle Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), PREVISCAN (View Previscan Review and Previscan Label ), COVERSYL /FRA/ (View Coversyl /fra/ Review and Coversyl /fra/ Label ). Patient was hospitalized.

6573434-7 | Hallucination, Auditory, Tinnitus
Adverse event was reported on Jan 28, 2010 by a Female patient taking Lasilix (View Usage) (Dosage: ) . Location: FRANCE , 83 years of age, Patient had the following side effects: hallucination, auditory, tinnitus (What is tinnitus?).

6557728-7 | Stevens-johnson Syndrome
on Dec 11, 2009 Female patient from FRANCE , 87 years of age, was diagnosed with anxiety (What is anxiety?) and was treated with Lasilix (View Usage). After Lasilix was administered, patient had the following side effects: stevens-johnson syndrome. Lasilix dosage: . During the same period patient was treated with HALDOL (View Haldol Review and Haldol Label ), INIPOMP (View Inipomp Review and Inipomp Label ), ZOPICLONE (View Zopiclone Review and Zopiclone Label ), PAROXETINE HCL (View Paroxetine Hcl Review and Paroxetine Hcl Label ), DILTIAZEM (View Diltiazem Review and Diltiazem Label ), FORMOTEROL W/BUDESONIDE (View Formoterol W/budesonide Review and Formoterol W/budesonide Label ), CARTROL (View Cartrol Review and Cartrol Label ), DIFFU K (View Diffu K Review and Diffu K Label ).

6554760-4 | Renal Failure, Tubulointerstitial Nephritis
on Jan 22, 2010 Female patient from FRANCE , 78 years of age, was treated with Lasilix (View Usage). Patient experienced the following unwanted or unexpected effects: renal failure, tubulointerstitial nephritis. Lasilix dosage: . During the same period patient was treated with SINTROM (View Sintrom Review and Sintrom Label ), SOTALEX (View Sotalex Review and Sotalex Label ), DISCOTRINE (View Discotrine Review and Discotrine Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), LAMOTRIGINE (View Lamotrigine Review and Lamotrigine Label ), IMOVANE (View Imovane Review and Imovane Label ), INIPOMP (View Inipomp Review and Inipomp Label ). Patient was hospitalized.

6554747-1 | Dehydration, Hypokalaemia, Renal Failure
Patient was taking Lasilix (View Usage). Patient had the following side effects: dehydration, hypokalaemia, renal failure on Jan 20, 2010 from FRANCE Additional patient health information: Female patient , 85 years of age, . Lasilix dosage: . During the same period patient was treated with AVLOCARDYL (View Avlocardyl Review and Avlocardyl Label ), ELISOR (View Elisor Review and Elisor Label ), EBIXA (View Ebixa Review and Ebixa Label ), REMINYL /UNK/ (View Reminyl /unk/ Review and Reminyl /unk/ Label ), DIAMICRON (View Diamicron Review and Diamicron Label ), VITAMINE B12 (View Vitamine B12 Review and Vitamine B12 Label ). Patient was hospitalized.

6550078-4 | Dehydration, Oliguria, Renal Failure Acute
Adverse event was reported on Jan 19, 2010 by a Male patient taking Lasilix (View Usage) (Dosage: ) . Location: FRANCE , 85 years of age, After Lasilix was administered, patient had the following side effects: dehydration, oliguria, renal failure acute. During the same period patient was treated with DIFFU K (View Diffu K Review and Diffu K Label ), TAHOR (View Tahor Review and Tahor Label ), CARDENSIEL (View Cardensiel Review and Cardensiel Label ), DAFALGAN (View Dafalgan Review and Dafalgan Label ), IMOVANE (View Imovane Review and Imovane Label ), COUMADIN (View Coumadin Review and Coumadin Label ), LEUPROLIDE ACETATE (View Leuprolide Acetate Review and Leuprolide Acetate Label ), NITRODERM (View Nitroderm Review and Nitroderm Label ). Patient was hospitalized.

6541907-9 | Eosinophil Count Increased, Lymphadenopathy, Pyrexia, Rash Papular, Renal Failure
on Jan 11, 2010 Male patient from FRANCE , 80 years of age, was treated with Lasilix (View Usage). Patient experienced the following unwanted or unexpected effects: eosinophil count increased, lymphadenopathy, pyrexia, rash papular, renal failure. Lasilix dosage: . During the same period patient was treated with LASILIX FAIBLE (View Lasilix Faible Review and Lasilix Faible Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), SEROPLEX (View Seroplex Review and Seroplex Label ), FORLAX (View Forlax Review and Forlax Label ), EQUANIL (View Equanil Review and Equanil Label ), CACIT D3 (View Cacit D3 Review and Cacit D3 Label ), CASODEX (View Casodex Review and Casodex Label ), COUMADIN (View Coumadin Review and Coumadin Label ). Patient was hospitalized.

6538770-9 | Gastritis Haemorrhagic, Hepatic Cirrhosis, Hepatorenal Syndrome, Lactic Acidosis, Portal Hypertension, Renal Failure, Shock Haemorrhagic
on Jan 04, 2010 Female patient from FRANCE , 55 years of age, was treated with Lasilix (View Usage). Patient had the following side effects: gastritis haemorrhagic, hepatic cirrhosis, hepatorenal syndrome, lactic acidosis, portal hypertension, renal failure, shock haemorrhagic. Lasilix dosage: . During the same period patient was treated with COVERSYL 2 MG (Daily Dose: 2 Milligram(s)) (View Coversyl 2 Mg Review and Coversyl 2 Mg Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), GLUCOPHAGE (View Glucophage Review and Glucophage Label ), CARDENSIEL (View Cardensiel Review and Cardensiel Label ).

6525185-2 | Cholestasis, Hypersensitivity, Pancreatitis, Pyrexia, Rash
Patient was taking Lasilix (View Usage). After Lasilix was administered, patient had the following side effects: cholestasis, hypersensitivity, pancreatitis, pyrexia, rash (What is rash?) on Dec 29, 2009 from FRANCE Additional patient health information: Female patient , 76 years of age, was diagnosed with erysipelas, thrombosis prophylaxis and. Lasilix dosage: . During the same period patient was treated with AUGMENTIN '125' (View Augmentin '125' Review and Augmentin '125' Label ), LOVENOX (View Lovenox Review and Lovenox Label ). Patient was hospitalized.

6518977-7 | Hyperkalaemia, Renal Failure Acute
Adverse event was reported on Dec 22, 2009 by a Female patient taking Lasilix (View Usage) (Dosage: ) . Location: FRANCE , 76 years of age, weighting 264.6 lb, Patient experienced the following unwanted or unexpected effects: hyperkalaemia, renal failure acute. During the same period patient was treated with COVERSYL /FRA/ (View Coversyl /fra/ Review and Coversyl /fra/ Label ), PREVISCAN (View Previscan Review and Previscan Label ), CRESTOR (View Crestor Review and Crestor Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), NITROGLYCERIN (View Nitroglycerin Review and Nitroglycerin Label ), METFORMIN HYDROCHLORIDE/PIOGLITAZONE HYDROCHLORIDE (View Metformin Hydrochloride/pioglitazone Hydrochloride Review and Metformin Hydrochloride/pioglitazone Hydrochloride Label ).

6518964-9 | Fall, Hypotension, Renal Failure
on Dec 16, 2009 Female patient from FRANCE , 92 years of age, was treated with Lasilix (View Usage). Patient had the following side effects: fall (What is fall?), hypotension, renal failure. Lasilix dosage: . During the same period patient was treated with DI ANTALVIC (View Di Antalvic Review and Di Antalvic Label ), CIBACENE (View Cibacene Review and Cibacene Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), ADANCOR (View Adancor Review and Adancor Label ), NITRODERM (View Nitroderm Review and Nitroderm Label ), CORDARONE (View Cordarone Review and Cordarone Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), KALEORID (View Kaleorid Review and Kaleorid Label ). Patient was hospitalized.

6503169-8 | Stevens-johnson Syndrome
on Dec 11, 2009 Female patient from FRANCE , 87 years of age, was diagnosed with anxiety (What is anxiety?) and was treated with Lasilix (View Usage). After Lasilix was administered, patient had the following side effects: stevens-johnson syndrome. Lasilix dosage: . During the same period patient was treated with HALDOL (View Haldol Review and Haldol Label ), INIPOMP (View Inipomp Review and Inipomp Label ), ZOPICLONE (View Zopiclone Review and Zopiclone Label ), PAROXETINE HCL (View Paroxetine Hcl Review and Paroxetine Hcl Label ), DILTIAZEM (View Diltiazem Review and Diltiazem Label ), FORMOTEROL W/BUDESONIDE (View Formoterol W/budesonide Review and Formoterol W/budesonide Label ), CARTROL (View Cartrol Review and Cartrol Label ), DIFFU K (View Diffu K Review and Diffu K Label ).

6503099-1 | Bradycardia, Dehydration, Ecchymosis, Fall
Patient was taking Lasilix (View Usage). Patient experienced the following unwanted or unexpected effects: bradycardia, dehydration, ecchymosis, fall (What is fall?) on Dec 09, 2009 from FRANCE Additional patient health information: Female patient , 97 years of age, was diagnosed with arrhythmia (What is arrhythmia?), pain (What is pain?) and. Lasilix dosage: . During the same period patient was treated with DIGITALINE NATIVELLE (View Digitaline Nativelle Review and Digitaline Nativelle Label ), COVERSYL COMP (View Coversyl Comp Review and Coversyl Comp Label ), PREVISCAN (View Previscan Review and Previscan Label ), LAMALINE (View Lamaline Review and Lamaline Label ). Patient was hospitalized.

6503012-7 | Interstitial Lung Disease
Adverse event was reported on Dec 11, 2009 by a Male patient taking Lasilix (View Usage) (Dosage: ) . Location: FRANCE , 85 years of age, Patient had the following side effects: interstitial lung disease. During the same period patient was treated with ZESTORETIC (View Zestoretic Review and Zestoretic Label ), ELISOR (View Elisor Review and Elisor Label ), ZYLORIC ^FRESENIUS^ (View Zyloric ^fresenius^ Review and Zyloric ^fresenius^ Label ), FELDENE (View Feldene Review and Feldene Label ).

6479964-0 | Haemodialysis, Hyperkalaemia, Hyperthermia, Lactic Acidosis, Renal Failure Acute, Septic Shock
on Nov 25, 2009 Female patient from FRANCE , 76 years of age, weighting 264.6 lb, was treated with Lasilix (View Usage). After Lasilix was administered, patient had the following side effects: haemodialysis, hyperkalaemia, hyperthermia, lactic acidosis, renal failure acute, septic shock. Lasilix dosage: . During the same period patient was treated with NITROGLYCERIN (View Nitroglycerin Review and Nitroglycerin Label ), METFORMIN HYDROCHLORIDE/PIOGLITAZONE HYDROCHLORIDE (View Metformin Hydrochloride/pioglitazone Hydrochloride Review and Metformin Hydrochloride/pioglitazone Hydrochloride Label ), COVERSYL /FRA/ (View Coversyl /fra/ Review and Coversyl /fra/ Label ), PREVISCAN (View Previscan Review and Previscan Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), CRESTOR (View Crestor Review and Crestor Label ), BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ).

6479917-2 | Interstitial Lung Disease
on Nov 10, 2009 Male patient from FRANCE , 85 years of age, was treated with Lasilix (View Usage). Patient experienced the following unwanted or unexpected effects: interstitial lung disease. Lasilix dosage: . During the same period patient was treated with ZESTORETIC (View Zestoretic Review and Zestoretic Label ), ELISOR (View Elisor Review and Elisor Label ), ZYLORIC ^FRESENIUS^ (View Zyloric ^fresenius^ Review and Zyloric ^fresenius^ Label ), FELDENE (View Feldene Review and Feldene Label ).

6477462-1 | Blood Creatinine Increased, Hyperkalaemia, Hypochloraemia, Hyponatraemia
Patient was taking Lasilix (View Usage). Patient had the following side effects: blood creatinine increased, hyperkalaemia, hypochloraemia, hyponatraemia on Nov 10, 2009 from FRANCE Additional patient health information: Male patient , 65 years of age, . Lasilix dosage: . Patient was hospitalized.

6477460-8 | Interstitial Lung Disease
Adverse event was reported on Nov 10, 2009 by a Male patient taking Lasilix (View Usage) (Dosage: ) . Location: FRANCE , 85 years of age, After Lasilix was administered, patient had the following side effects: interstitial lung disease. During the same period patient was treated with ZESTORETIC (View Zestoretic Review and Zestoretic Label ), ELISOR (View Elisor Review and Elisor Label ), ZYLORIC ^FRESENIUS^ (View Zyloric ^fresenius^ Review and Zyloric ^fresenius^ Label ), FELDENE (View Feldene Review and Feldene Label ).

6477459-1 | Encephalopathy, Myoclonus, Renal Impairment
on Nov 10, 2009 Female patient from FRANCE , 92 years of age, was treated with Lasilix (View Usage). Patient experienced the following unwanted or unexpected effects: encephalopathy, myoclonus, renal impairment. Lasilix dosage: . During the same period patient was treated with AXEPIM (View Axepim Review and Axepim Label ), AMIKLIN (View Amiklin Review and Amiklin Label ), DIAMOX SRC (View Diamox Src Review and Diamox Src Label ), ESOMEPRAZOLE (View Esomeprazole Review and Esomeprazole Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), ARIXTRA (View Arixtra Review and Arixtra Label ). Patient was hospitalized.

5653069-0 | Rash Pruritic
on Feb 22, 2008 Female patient from FRANCE , 80 years of age, was diagnosed with cardiac failure and was treated with Lasilix (View Usage). Patient had the following side effects: rash pruritic. Lasilix dosage: . During the same period patient was treated with PERINDOPRIL (Daily Dose: 4 Milligram(s)) (View Perindopril Review and Perindopril Label ), PREVISCAN (View Previscan Review and Previscan Label ), SOTALOL HCL (View Sotalol Hcl Review and Sotalol Hcl Label ), LEXOMIL (View Lexomil Review and Lexomil Label ). Patient was hospitalized.

5101269-0 | Blood Creatine Phosphokinase Increased, Condition Aggravated, Myalgia, Renal Failure, Renal Failure Chronic
Patient was taking Lasilix (View Usage). After Lasilix was administered, patient had the following side effects: blood creatine phosphokinase increased, condition aggravated, myalgia, renal failure, renal failure chronic on Mar 30, 2006 from Additional patient health information: Female patient , 49 years of age, weighting 286.6 lb, was diagnosed with essential hypertension, asthma (What is asthma?), hypercholesterolaemia, sleep disorder (What is sleep disorder?) and. Lasilix dosage: . During the same period patient was treated with VENTOLIN (View Ventolin Review and Ventolin Label ), MONO TILDIEM (View Mono-tildiem Review and Mono-tildiem Label ), SERETIDE (View Seretide Review and Seretide Label ), EZETROL /GFR/ (View Ezetrol /gfr/ Review and Ezetrol /gfr/ Label ), ZOLPIDEM TARTRATE (View Zolpidem Tartrate Review and Zolpidem Tartrate Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), DISCOTRINE (View Discotrine Review and Discotrine Label ), DAFALGAN (View Dafalgan Review and Dafalgan Label ). Patient was hospitalized.

5099652-5 | Anxiety, Bacterial Infection, Neutropenia, Systemic Inflammatory Response Syndrome
Adverse event was reported on Aug 30, 2006 by a Female patient taking Lasilix (View Usage) (Dosage: ) was diagnosed with anxiety (What is anxiety?), systemic inflammatory response syndrome and. Location: , 88 years of age, Patient experienced the following unwanted or unexpected effects: anxiety (What is anxiety?), bacterial infection (What is bacterial infection?), neutropenia, systemic inflammatory response syndrome. During the same period patient was treated with PRIMPERAN TAB (View Primperan Tab Review and Primperan Tab Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), INIPOMP (View Inipomp Review and Inipomp Label ), RIVOTRIL (View Rivotril Review and Rivotril Label ), CIFLOX (View Ciflox Review and Ciflox Label ), ROCEPHIN (View Rocephin Review and Rocephin Label ), NEUPOGEN (View Neupogen Review and Neupogen Label ).

5098887-5 | Hyponatraemia, Renal Failure Acute
on Aug 16, 2006 Female patient from , 91 years of age, weighting 152.1 lb, was treated with Lasilix (View Usage). Patient had the following side effects: hyponatraemia, renal failure acute. Lasilix dosage: . During the same period patient was treated with LOPRIL (View Lopril Review and Lopril Label ), ALDALIX (View Aldalix Review and Aldalix Label ), LEXOMIL (View Lexomil Review and Lexomil Label ), MOPRAL (View Mopral Review and Mopral Label ), BETAHISTINE (View Betahistine Review and Betahistine Label ), XOLAAM (View Xolaam Review and Xolaam Label ), LOPERAMIDE (View Loperamide Review and Loperamide Label ). Patient was hospitalized.

5096324-8 | Benign Prostatic Hyperplasia, Fluid Retention, Kidney Enlargement, Oedema, Splenomegaly, Urinary Retention, Weight Increased
on May 29, 2006 Male patient from , 76 years of age, weighting 207.2 lb, was diagnosed with essential hypertension, diabetes mellitus and was treated with Lasilix (View Usage). After Lasilix was administered, patient had the following side effects: benign prostatic hyperplasia, fluid retention, kidney enlargement, oedema, splenomegaly, urinary retention, weight increased. Lasilix dosage: . During the same period patient was treated with ACTOS (View Actos Review and Actos Label ), KALEORID (View Kaleorid Review and Kaleorid Label ), GLUCOR (View Glucor Review and Glucor Label ), AMIODARONE HCL (View Amiodarone Hcl Review and Amiodarone Hcl Label ), NOVONORM (View Novonorm Review and Novonorm Label ), EUPRESSYL (View Eupressyl Review and Eupressyl Label ), ORBENIN CAP (View Orbenin Cap Review and Orbenin Cap Label ), DOLIPRANE (View Doliprane Review and Doliprane Label ). Patient was hospitalized.

5096322-4 | Dehydration, Renal Failure Acute
Patient was taking Lasilix (View Usage). Patient experienced the following unwanted or unexpected effects: dehydration, renal failure acute on Aug 29, 2006 from Additional patient health information: Female patient , 87 years of age, . Lasilix dosage: . During the same period patient was treated with TRIATEC (View Triatec Review and Triatec Label ), AUGMENTIN (View Augmentin Review and Augmentin Label ), MORPHINE SULFATE (View Morphine Sulfate Review and Morphine Sulfate Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), MOPRAL (View Mopral Review and Mopral Label ), HEPARIN (View Heparin Review and Heparin Label ), ACUPAN (View Acupan Review and Acupan Label ). Patient was hospitalized.

5091276-9 | Abnormal Behaviour, Confusional State, Disorientation, Hepatic Encephalopathy
Adverse event was reported on Aug 21, 2006 by a Female patient taking Lasilix (View Usage) (Dosage: ) was diagnosed with diabetes mellitus and. Location: , 50 years of age, Patient had the following side effects: abnormal behaviour, confusional state, disorientation, hepatic encephalopathy. During the same period patient was treated with ALDACTONE (View Aldactone Review and Aldactone Label ), NEXIUM (View Nexium Review and Nexium Label ), LANTUS (View Lantus Review and Lantus Label ), HUMALOG (View Humalog Review and Humalog Label ), FORLAX (View Forlax Review and Forlax Label ). Patient was hospitalized.

5091274-5 | Dehydration, Hepatic Encephalopathy, Renal Failure Acute
on Aug 21, 2006 Female patient from , 50 years of age, weighting 132.3 lb, was diagnosed with oedema, muscle disorder (What is muscle disorder?) and was treated with Lasilix (View Usage). After Lasilix was administered, patient had the following side effects: dehydration, hepatic encephalopathy, renal failure acute. Lasilix dosage: . During the same period patient was treated with ALDACTONE (View Aldactone Review and Aldactone Label ), XANAX (View Xanax Review and Xanax Label ), DEROXAT (View Deroxat Review and Deroxat Label ). Patient was hospitalized.

5087359-X | Escherichia Urinary Tract Infection, Hyponatraemia, Renal Failure Acute
on Aug 16, 2006 Female patient from , 91 years of age, weighting 152.1 lb, was treated with Lasilix (View Usage). Patient experienced the following unwanted or unexpected effects: escherichia urinary tract infection, hyponatraemia, renal failure acute. Lasilix dosage: . During the same period patient was treated with LOPRIL (View Lopril Review and Lopril Label ), ALDALIX (View Aldalix Review and Aldalix Label ), LEXOMIL (View Lexomil Review and Lexomil Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), BETAHISTINE (View Betahistine Review and Betahistine Label ), XOLAAM (View Xolaam Review and Xolaam Label ), LOPERAMIDE (View Loperamide Review and Loperamide Label ). Patient was hospitalized.

5086294-0 | Abortion Induced, Caudal Regression Syndrome, Limb Malformation
Patient was taking Lasilix (View Usage). Patient had the following side effects: abortion induced, caudal regression syndrome, limb malformation on Aug 16, 2006 from Additional patient health information: Female patient , 34 years of age, . Lasilix dosage: . During the same period patient was treated with ALDOMET (View Aldomet Review and Aldomet Label ), ASPEGIC 1000 (View Aspegic 1000 Review and Aspegic 1000 Label ), OROCAL (View Orocal Review and Orocal Label ), TENORMIN (View Tenormin Review and Tenormin Label ), NEORECORMON (View Neorecormon Review and Neorecormon Label ). Patient was hospitalized.

5084481-9 | Blood Creatinine Increased, Renal Failure
Adverse event was reported on Aug 16, 2006 by a Female patient taking Lasilix (View Usage) (Dosage: ) was diagnosed with essential hypertension, atrial fibrillation (What is atrial fibrillation?) and. Location: , 82 years of age, After Lasilix was administered, patient had the following side effects: blood creatinine increased, renal failure. During the same period patient was treated with BACTRIM (View Bactrim Review and Bactrim Label ), PREVISCAN (View Previscan Review and Previscan Label ), TENORMIN (View Tenormin Review and Tenormin Label ), TAREG (View Tareg Review and Tareg Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), DIGOXIN (View Digoxin Review and Digoxin Label ). Patient was hospitalized.

5083339-9 | Coma, Dehydration, Diabetes Mellitus, Disease Progression, Hypernatraemia, Infection
on Aug 09, 2006 Male patient from , 92 years of age, was diagnosed with essential hypertension and was treated with Lasilix (View Usage). Patient experienced the following unwanted or unexpected effects: coma, dehydration, diabetes mellitus, disease progression, hypernatraemia, infection (What is infection?). Lasilix dosage: . During the same period patient was treated with CORDARONE (View Cordarone Review and Cordarone Label ), DEPAKENE (View Depakene Review and Depakene Label ), DIFFU K (View Diffu K Review and Diffu K Label ), STILNOX (View Stilnox Review and Stilnox Label ), DOLIPRANE (View Doliprane Review and Doliprane Label ).

5080412-6 | Cardiac Failure
on Jun 05, 2001 Male patient from FRANCE , weighting 185.2 lb, was diagnosed with ill-defined disorder, cardiac failure congestive and was treated with Lasilix (View Usage). Patient had the following side effects: cardiac failure. Lasilix dosage: . During the same period patient was treated with COVERSYL (Daily Dose: 8 Mg.) (View Coversyl Review and Coversyl Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), ACETYLSALICYLIC ACID SRT (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ), TRINITRINE (View Trinitrine Review and Trinitrine Label ). Patient was hospitalized.

5078098-X | Caesarean Section, Dysmorphism, Heart Disease Congenital, Lordosis, Neonatal Respiratory Distress Syndrome, Premature Baby, Solitary Kidney
Patient was taking Lasilix (View Usage). After Lasilix was administered, patient had the following side effects: caesarean section, dysmorphism, heart disease congenital, lordosis, neonatal respiratory distress syndrome, premature baby, solitary kidney on Aug 03, 2006 from Additional patient health information: Female patient , weighting 5.20 lb, was diagnosed with hypertension, diabetes mellitus insulin-dependent, thyroiditis and. Lasilix dosage: . During the same period patient was treated with TRIATEC (View Triatec Review and Triatec Label ), UMULINE (View Umuline Review and Umuline Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), HUMALOG (View Humalog Review and Humalog Label ), AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), LOXEN (View Loxen Review and Loxen Label ), MEDIATENSYL (View Mediatensyl Review and Mediatensyl Label ), CELESTENE (View Celestene Review and Celestene Label ).

5078095-4 | Cytolytic Hepatitis, Jaundice, Renal Failure Acute
Adverse event was reported on Aug 03, 2006 by a Male patient taking Lasilix (View Usage) (Dosage: ) . Location: , 75 years of age, Patient experienced the following unwanted or unexpected effects: cytolytic hepatitis, jaundice (What is jaundice?), renal failure acute. Patient was hospitalized.

5075465-5 | Blood Creatine Phosphokinase Increased, Blood Creatinine Increased, Renal Failure Acute, Rhabdomyolysis
on Aug 03, 2006 Female patient from FRANCE , 80 years of age, was diagnosed with hypertension and was treated with Lasilix (View Usage). Patient had the following side effects: blood creatine phosphokinase increased, blood creatinine increased, renal failure acute, rhabdomyolysis. Lasilix dosage: . During the same period patient was treated with ISOBAR (View Isobar Review and Isobar Label ), VASTAREL (70 Mg/day) (View Vastarel Review and Vastarel Label ), TAREG (40 Mg, Qd) (View Tareg Review and Tareg Label ). Patient was hospitalized.

5073380-4 | Cardio-respiratory Arrest, Ventricular Fibrillation
on Aug 03, 2006 Male patient from , 58 years of age, weighting 194.0 lb, was diagnosed with hypercholesterolaemia and was treated with Lasilix (View Usage). After Lasilix was administered, patient had the following side effects: cardio-respiratory arrest, ventricular fibrillation. Lasilix dosage: . During the same period patient was treated with VASTEN (View Vasten Review and Vasten Label ), CARDENSIEL (View Cardensiel Review and Cardensiel Label ), SEROPLEX (View Seroplex Review and Seroplex Label ), COVERSYL (View Coversyl Review and Coversyl Label ), GLUCOPHAGE (View Glucophage Review and Glucophage Label ), DAFALGAN (View Dafalgan Review and Dafalgan Label ), ASPEGIC 1000 (View Aspegic 1000 Review and Aspegic 1000 Label ), DIAMICRON (View Diamicron Review and Diamicron Label ).

5067683-7 | Renal Failure Acute, Rhabdomyolysis
Patient was taking Lasilix (View Usage). Patient experienced the following unwanted or unexpected effects: renal failure acute, rhabdomyolysis on Jul 27, 2006 from Additional patient health information: Female patient , 80 years of age, was diagnosed with dyspnoea, essential hypertension and. Lasilix dosage: . During the same period patient was treated with TAREG (View Tareg Review and Tareg Label ), TRIATEC (View Triatec Review and Triatec Label ), VASTAREL (View Vastarel Review and Vastarel Label ), ISOBAR (View Isobar Review and Isobar Label ). Patient was hospitalized.

5065806-7 | Anaemia, International Normalised Ratio Increased, Melaena
Adverse event was reported on Jul 24, 2006 by a Female patient taking Lasilix (View Usage) (Dosage: Unk) was diagnosed with cardiac failure, prophylaxis against gastrointestinal ulcer, hypercholesterolaemia, thrombosis prophylaxis and. Location: FRANCE , 82 years of age, Patient had the following side effects: anaemia, international normalised ratio increased, melaena. During the same period patient was treated with PANTOPRAZOLE SODIUM (Unk) (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), COVERSYL (Unk) (View Coversyl Review and Coversyl Label ), ATORVASTATIN CALCIUM (Unk) (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), PREVISCAN (View Previscan Review and Previscan Label ), LOVENOX (View Lovenox Review and Lovenox Label ), ASPIRIN (Unk) (View Aspirin Review and Aspirin Label ), PLAVIX (Unk) (View Plavix Review and Plavix Label ). Patient was hospitalized.

5062003-6 | Coma, Condition Aggravated, Escherichia Urinary Tract Infection, Hyponatraemia, Renal Failure, Renal Impairment, Staphylococcal Infection, Vascular Bypass Graft
on Jul 17, 2006 Female patient from , 51 years of age, weighting 116.8 lb, was treated with Lasilix (View Usage). After Lasilix was administered, patient had the following side effects: coma, condition aggravated, escherichia urinary tract infection, hyponatraemia, renal failure, renal impairment, staphylococcal infection (What is staphylococcal infection?), vascular bypass graft. Lasilix dosage: . During the same period patient was treated with TRILEPTAL (View Trileptal Review and Trileptal Label ), ESIDRIX (View Esidrix Review and Esidrix Label ), OFLOCET (View Oflocet Review and Oflocet Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), AUGMENTIN '125' (View Augmentin '125' Review and Augmentin '125' Label ). Patient was hospitalized.

5057019-X | Lichenoid Keratosis
on Jul 10, 2006 Female patient from , 72 years of age, was diagnosed with cardiac failure, anxiety (What is anxiety?), atrial fibrillation (What is atrial fibrillation?), atrial flutter, sleep disorder (What is sleep disorder?) and was treated with Lasilix (View Usage). Patient experienced the following unwanted or unexpected effects: lichenoid keratosis. Lasilix dosage: . During the same period patient was treated with ATARAX (View Atarax Review and Atarax Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), PREVISCAN (View Previscan Review and Previscan Label ), NOCTRAN (View Noctran Review and Noctran Label ), CORDARONE (View Cordarone Review and Cordarone Label ). Patient was hospitalized.

5055965-4 | Fall, Rhabdomyolysis
Patient was taking Lasilix (View Usage). Patient had the following side effects: fall (What is fall?), rhabdomyolysis on Jul 11, 2006 from Additional patient health information: Male patient , 85 years of age, weighting 183.0 lb, was diagnosed with hypertension and. Lasilix dosage: . During the same period patient was treated with CIBADREX ^CIBA GEIGY^ (View Cibadrex ^ciba-geigy^ Review and Cibadrex ^ciba-geigy^ Label ), ANAFRANIL (View Anafranil Review and Anafranil Label ), AMLOR (View Amlor Review and Amlor Label ). Patient was hospitalized.